Hans Hull

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

PLRX

Current role

Board Member

2016-01-01–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2024	Pliant Therapeutics, Inc. (PLRX)	Chief Business Officer	$444,392	—	$549,360	$811,440	$195,532	$14,600	$2,015,324
2023	Pliant Therapeutics, Inc. (PLRX)	Chief Business Officer	$427,300	—	$1,871,100	$1,883,664	$170,920	$4,293	$4,357,277
2022	Pliant Therapeutics, Inc. (PLRX)	Chief Business Officer	$407,000	—	$1,642,517	$880,594	$211,640	$13,000	$3,154,751
2021	Pliant Therapeutics, Inc. (PLRX)	Chief Business Officer	$385,735	—	—	$1,071,142	$185,153	$11,600	$1,653,630
2020	Pliant Therapeutics, Inc. (PLRX)	Chief Business Officer	$372,491	—	—	$279,025	$176,951	$11,400	$839,867
2019	Pliant Therapeutics, Inc. (PLRX)	Chief Business Officer	$355,137	$75,000	—	$268,560	$136,369	$11,200	$846,266

Earnings-call appearances and filed executive appointments or departures, newest first.